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Abstract
Loss-of-function mutations in CLMP have been found in patients with Congenital Short Bowel Syndrome (CSBS), suggesting
that its encoded protein plays a major role in intestinal development. CLMP is a membrane protein that co-localizes with
tight junction proteins, but its function is largely unknown. We expressed wild-type (WT)-CLMP and a mutant-CLMP
(associated with CSBS) in human intestinal epithelial T84 cells that, as we show here, do not produce endogenous CLMP. We
investigated the effects of WT-CLMP and mutant-CLMP proteins on key cellular processes that are important for intestinal
epithelial development, including migration, proliferation, viability and transepithelial resistance. Our data showed that
expression of WT-CLMP or mutant-CLMP does not affect any of these processes. Moreover, our aggregation assays in CHO
cells show that CLMP does not act as a strong adhesion molecule. Thus, our data suggest that, in the in vitro model systems
we used, the key processes involved in intestinal epithelial development appear to be unaffected by WT-CLMP or mutant-
CLMP. Further research is needed to determine the role of CLMP in the development of the intestine.
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Introduction
CLMP (coxsackie- and adenovirus receptor-like membrane
protein) is a membrane protein that belongs to the CTX (cortical
thymocyte marker in Xenopus) family of proteins [1]. The precise
function of CLMP is largely unknown although several suggestions
have been made. For instance, it has been suggested that CLMP
plays a role in immunological processes [1,2]. This is based on the
fact that there is a high homology between CLMP and Junctional
adhesion molecules (JAMs), both belonging to the CTX family of
proteins. It is known that JAMs are important for transmigration
of leukocytes to inflammatory sites [3]. This hypothesis was further
supported by the finding that TNFa, a pro-inflammatory cytokine,
is able to regulate CLMP expression [2]. In addition, it has been
suggested that CLMP plays a role in cell-cell adhesion, based on
the finding that it co-localizes with the tight junction proteins
zonula occludens 1 (ZO-1) [1,4,5] and occluding [1]. Moreover,
transfection of human CLMP in Chinese Hamster Ovary cells
(CHO) induces cell aggregation [1,6]. In addition, transfection of
human CLMP into Madin-Darby canine kidney (MDCK)
epithelial cells induces transepithelial electrical resistance (TER),
suggesting a role for CLMP in the junction-barrier function of
intestinal epithelial cells [1].
Loss-of-function mutations in CLMP were identified in patients
with Congenital Short Bowel Syndrome (CSBS) [4]. A missense
mutation was identified (V124D) in one of these CSBS patients.
Transient transfection of this mutant-CLMP (CLMP containing
the missense mutation V124D) in CHO and T84 cells resulted in
mislocalization of CLMP and in an increased cytoplasmic pool of
ZO-1 [4]. As tight junction proteins like ZO-1 play a role in cell
proliferation [7,8], it has been suggested that loss-of-function of
CLMP would probably affect proliferation of human small
intestinal cells during foetal development and thereby causing a
shortened small intestine [4]. As the function of CLMP is still
obscure, we aimed to gain a better understanding of the functional
cellular role of CLMP.
Materials and Methods
Construction of plasmids for transient transfection of
Chinese Hamster Ovary cells
A pCMV6-CLMP-green fluorescent protein (GFP) vector was
obtained from Origene (Rockville, MD, USA). The CLMP
missense mutation (c.730T.A, p.V124D) was introduced in this
vector by site-directed mutagenesis (Stratagene, Amstelveen, Santa
Clara, CA, USA) (for primer sequences see our previous
publication) [4]. The wild-type (WT) and mutant cDNA were
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amplified using the primers CCGCC-NheI, 59-
ATGTCCCTCCTCCTTCTCC-39, and GGGCGC-XhoI, 59-
TCAGACCGTTTGGAAGGCTCTG-39. The amplification
was performed using Phusion High-fidelity DNA polymerase
(Finnzymes, Helsinki, Finland). The PCR products were inserted
into PCR 2.1-TOPO plasmid (Invitrogen, Carlsbad, CA, USA).
The PCR 2.1 Topo constructs were digested by NheI and XhoI
restriction enzymes and the fragments were cloned into the vector
pCMV-internal ribosomal re-entry site (IRES) coupled to eGFP
(GFP-like protein). The clones were checked by direct sequencing.
Construction of viral vectors for transduction of T84 cells
The pCMV-IRES-EGFP vectors, which were constructed as
described above and contained both WT- and mutant cDNA
(c.730T.A, p.V124D) of CLMP, were used as a template for
amplification using the primers ACCA-NcoI-Myc, 59-
ATGTCCCTCCTCCTTCTC-39 and AACA-XhoI- 59-TCA-
GACCGTTTGGAAGGCTCTG-39. The PCR products were
digested with NcoI and XhoI and the fragments were cloned into
the vector pEntr4. The clones were checked by digestion with NcoI
and XhoI and direct sequencing. The inserts were subsequently
cloned into the vector pLenti-CMV-Neo using lambda phage-
based site-specific recombination and the GatewayH recombina-
tion cloning technology (Invitrogen).
Production of lentiviral CLMP
For the production of the viruses, 2.66106 HEK293 cells were
grown in Dulbecco’s modified Eagle medium (DMEM) supple-
mented with 10% heat-inactivated foetal bovine serum (FBS,
Invitrogen), 1% antibiotic solution (penicillin–streptomycin, In-
vitrogen) and 1% sodium pyruvate. The cells were maintained at
37uC in a humidified atmosphere with 5% CO2. Co-transfection
of both WT and mutant pLenti-CMV-CLMP (V124D)-Neo with
pVSV-G and pCMVdR8.1 was performed using the CaCl2
method. The cells were subsequently grown overnight. After
24 hours the medium was changed to DMEM supplemented with
10% heat-inactivated foetal bovine serum (FBS, Invitrogen) and
1% antibiotic solution (penicillin–streptomycin, Invitrogen). After
24 and 48 hours, the medium containing the virus was collected
and stored at 4uC. Fresh medium was added to the cells. The
collected medium was filtered using a polyvinylidene difluoride
membrane-based filter to remove HEK293 cells.
Cell culture
Chinese hamster ovary (CHO) and human intestinal epithelial
T84 cells were grown in commercially available alpha modifica-
tion of eagle’s medium and DMEM/F-12 (both Invitrogen)
respectively, supplemented with 4.5 mg/L L-glutamine, 10%
heat-inactivated foetal bovine serum (FBS, Invitrogen) and 1%
antibiotic solution (penicillin–streptomycin, Invitrogen). The cells
were maintained at 37uC in a humidified atmosphere with 5%
CO2.
Production of stably transduced CLMP T84 cell lines
For transduction the virus-containing solution and Hexadi-
methrine Bromide (Sigma; 4 mg/ml PBS) were added to T84
cells. The cells were then grown overnight at 37uC in a humidified
atmosphere with 5% CO2. After 24 hours the medium was
changed and the cells were grown till a confluency of 80% was
reached. Transduction efficiency was checked by qPCR and
Western blot analysis (see figure 1A).
Real-time PCR
Expression of CLMP in the transduced T84 cells was quantified
with Quantitative Polymerase Chain Reaction (qPCR). Trans-
duced T84 cells were lysed and mRNA was isolated according to
the manufacturer’s instructions (GeneJETTM RNA Purification
Kit, Fermentas). The GAPDH gene was used as an internal
standard for normalization. mRNA was used as a template to
synthesise cDNA. PCR was performed using the primers (CLMP-
F) 59-GAAGGAAAGCTGTGTGGTG- 39 and (CLMP-R) 59-
CACTATGCCTGTCACTGCTC-39 for CLMP and (GAPDH-F)
59-CATTTCCTGGTATGACAACG- 39 and (GAPDH-R) 59-
GTCCAGGGGTCTTACTCCTT- 39 for GAPDH and the
following amplification program: 15 minutes 95uC, 40 cycles
15 seconds 95uC, 1 minute 60uC. Each amplification reaction was
run in triplicate using 10 ng of cDNA, 150 nM of both forward
Figure 1. Expression of CLMP in T84 cells transduced with wild-
type (WT)-CLMP, mutant-CLMP (V124D), RFP and an empty
vector. There is no endogenous expression of CLMP in T84 cells (see
the right lane (empty vector)). A. WT-CLMP and mutant-CLMP (V124D)
mRNA were equally expressed in the transduced T84 cells as measured
by real-time PCR. B. Western blots showed that WT-CLMP and mutant-
CLMP (V124D) (at 41 kDa) protein were equally expressed. The 100 kDa
band is an aspecific band derived from the vector.
doi:10.1371/journal.pone.0054649.g001
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and reverse primers, and 16 SYBR green master mix (ABCM-
221/A, Westburg, Leusden, the Netherlands) in a total volume of
10 mL. The results were analysed by StepOnetm software v2.2 and
recalculated manually using the Comparative CT Method.
Western blotting
Cells were harvested with lysis buffer (100 mM NaCl, 20 mM
Tris-HCl pH 7.6, Triton X-100 and protease inhibitors (Roche,
Almere, the Netherlands)). After incubation on ice for 30 minutes,
the lysate was centrifuged for 5 minutes at 14,000 rpm at 4uC.
Protein concentrations were determined using the BCA protein
assay (Pierce Biotechnologies, Rockford, IL, USA) and measured
on a NanoDropH ND-1000 (Thermo Scientific, Waltham, MA,
USA).
Protein extracts (40 mg) were resolved on an SDS/15%
polyacrylamide gel, transferred on to a nitrocellulose membrane
and blocked with dried milk powder in Tris-buffered saline with
0.1% Tween 20 for 1 hour at room temperature. The membrane
was then incubated with primary antibody rabbit polyclonal
antibody for CLMP (anti-AP000926.6, Sigma-Aldrich) in 1:500
dilution for 1 hour at room temperature. After 1 hour incubation
with the secondary antibody goat anti-rabbit conjugated with
Horseradish peroxidase (1:1,000; Bio-Rad, Hercules, CA, USA) at
room temperature, the proteins were visualized using enhanced
chemiluminescence reagent (Lumi-Light Western Blotting Sub-
strate, Roche).
Scratch/wound healing assay
Control T84 cells or T84 cells expressing WT-CLMP or
mutant-CLMP (V124D) were cultured on glass-bottom petridishes
(1.56105 per dish) for 7 days after which they develop a polarized
monolayer with functional tight junctions. The dish was mounted
on a microscope for live imaging. Monolayers were scratched with
a micropipette and incubated in serum-deprived culture medium.
After 24 hours of incubation, the rate of migration into the scratch
was determined and presented as mm/24 hours. Experiments were
performed in triplicate and data were expressed as mean 6 SD.
BrdU Cell Proliferation Assay
Cell proliferation was measured using a BrdU cell proliferation
assay (Cell Signalling Technologies, Danvers, MA, USA) that
detects 5-bromo-29-deoxyuridine (BrdU) incorporated into cellular
DNA during cell proliferation using an anti-BrdU antibody. T84
cells (1.56105) (control, WT-CMP or mutant-CLMP (V124D))
were plated and cultured for 2 days. BrdU was included in the
culture medium at a final concentration of 10 mM and added to a
monolayer of T84 cells (control, WT-CMP or mutant-CLMP
(V124D)). After 24 hours, the labelling medium was removed, cells
were fixed and BrdU incorporation was measured according to the
manufacturer’s instructions. Experiments were performed in
triplicate and data were expressed as mean 6 SD.
XTT cell viability assay
Cell viability was measured using an XTT cell viability assay kit
(Cell Signalling Technologies), a colorimetric assay that detects
cellular metabolic activities that only occur in viable cells. T84
cells (1.56105) were plated and cultured for 2 days. The yellow
tetrazolium salt XTT was then added to a monolayer of T84 cells
(control, WT-CMP or mutant-CLMP (V124D)) at a final
concentration of 20 mg/ml. After 4 h of incubation, the formazan
dye that formed was quantified by measuring the optical density
(OD) at wavelength 450 nm using a spectrophotometer. The OD
measured at wavelength 690 nm was used as background
reference. The specific OD was calculated by substracting the
OD measured at wavelength 690 nm from the OD measured at
wavelength 450 nm. Experiments were performed in triplicate and
data were expressed as mean 6 SD.
Measurement of transepithelial electrical resistance in
monolayer T84 cultures
T84 cells were grown on polycarbonate 24-wells Transwell filter
inserts (Corning Costar, Corning, NY, USA) for 7 days.
Transepithelial electrical resistance was measured using an
epithelial Volt/Ohm-meter (World Precision Instruments, Sar-
asota, FL, USA). Experiments were performed in triplicate and
data were expressed as mean 6 SD.
Transfection of CHO cells for aggregation assays
WT or mutant pCMV-CLMP (V124D)-IRES-EGFP was
transfected into CHO cells (1.56105) with Lipofectamine 2000
Transfection Reagent (Invitrogen) in a 1:3 dilution, and transfec-
tion efficiencies were evaluated by measuring EGFP expression by
flow cytometry (around 50% efficiency).
Aggregation assays
The bottoms of the wells of a 96-well plate were covered with
semi-solid agar medium (100 mg Bacto-agar in 15 ml Ringer’s salt
solution) to prevent cell-substratum adhesion. Thereafter, a single
cell suspension was added and incubated at 37uC in a humidified
atmosphere with 5% CO2 for 24 hours and 48 hours. Aggregation
was evaluated under an inverted microscope with a 46 objective
and pictures were taken at both time points.
Results
Viral transduction of T84 cells
T84 colonic adenocarcinoma cells grow to confluent polarized
monolayers that exhibit functional tight junctions and have been
used extensively as a model to study intestinal tight junction
integrity [9–11]. We found that T84 cells do not endogenously
express CLMP (Figure 1), which makes this cell line a suitable
model system to explore the effect of CLMP and CSBS-related
CLMP mutants on epithelial functions related to the tight
junction. For this, we stably transduced both WT-CLMP and
mutant-CLMP (CLMP containing the missense mutation V124D).
WT-CLMP and mutant-CLMP (V124D) were equally expressed
in the transduced T84 cells as measured by real-time PCR (see
Figure 1A). This result was confirmed by Western blot (see
Figure 1B).
CLMP does not affect migration of T84 cells
To assess whether CLMP plays a role in intestinal cell
migration, we performed a wound healing experiment. T84 cell
monolayers were wounded and incubated in serum-deprived
medium for 24 hours. There was no significant difference in the
rate of directional cell migration (distance travelled/time unit)
between the three groups (see Figure 2A). We concluded that
overexpression of WT-CLMP or mutant-CLMP (V124D) does not
affect the directed migration of T84 cells.
CLMP does not interfere with proliferation of T84 cells
Proliferation of control and WT-CLMP or mutant-CLMP
(V124D) expressing cells was quantified by measuring BrdU
incorporation. There was no difference in BrdU incorporation
between the three groups (see figure 2B). These data show that
No Role for CLMP in Intestinal Epithelial Cells
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overexpression of WT-CLMP or mutant-CLMP (V124D) does not
interfere with T84 cell proliferation.
CLMP does not affect cell viability in T84 cells
To assess whether CLMP improved cell viability, we performed
the in vitro XXT-based Toxicology Assay. T84 cells (1.56105) were
plated and cultured for 2 days. After 4 hours of incubation with
20 mg/ml XTT, the specific absorbance was not significantly
different between the three groups (see figure 2C). These data
demonstrate that overexpression of WT-CLMP or mutant-CLMP
(V124D) does not affect the viability of the T84 cells.
CLMP does not increase transepithelial electrical
resistance in T84 cells
Transepithelial electrical resistance is a measurement of ion flux
over a polarized epithelial monolayer and can be used as a model
for the junction-barrier function of tight junctions. Others have
shown that overexpression of CLMP in MDCK cells, which do
not express CLMP endogenously, increases the transepithelial
resistance. We therefore assessed whether transfection of human
CLMP into T84 cells influenced the transepithelial resistance.
However, we observed no significant difference in transepithelial
resistance between the control (not transduced) T84 cells, the T84
cells transduced with the WT-CLMP virus and the T84 cells
transduced with the mutant-CLMP (V124D) virus (see Figure 2D).
Thus, WT-CLMP and mutant-CLMP (V124D) do not increase or
interfere with the transepithelial electrical resistance of a T84 cell
monolayer.
CLMP does not act as a strong cell-cell adhesion
molecule
To determine the ability of CLMP to cause cell-cell adhesion,
and the effect of the missense mutation (V124D) on its ability to do
so, we decided to perform a slow aggregation assay, using CHO
cells that do not aggregate at all in this assay. As a positive control,
we transfected CHO cells with a Cadherin 1 or also called epithelial
or E-cadherin (CDH1) vector (which is a known cell-cell adhesion
protein) which resulted in large aggregates (see Figure 3).
Figure 2. Overexpression of wild type (WT)-CLMP andmutant-CLMP (V124D) in human intestinal epithelial T84 cells does not affect
wound healing/migration, cell proliferation, viability, and trans-epithelial electrical resistance. A. Cell monolayers were wounded and
incubated in serum-deprived medium for 24 hours. The rate of directional cell migration (distance travelled/time unit) and wound closure were
determined. B. Proliferation was quantified measuring BrdU incorporation using a BrdU cell proliferation assay. There was no significant difference in
the specific optical density (OD) (the measured OD at wavelength 370 nm minus the measured OD at wavelength 492 nm) between the three
groups. C. Cell viability was estimated using an in vitro Toxicology Assay Kit XTT-based. XTT was added to the cells at a final concentration of 20 mg/
ml. After 4 hours of incubation the OD was measured at 450 nm using the 690 nm absorbance as the background. There was no significant
difference between the three groups. D. Transepithelial electrical resistance was measured in confluent cell monolayers cultured on Transwell filter
inserts.
doi:10.1371/journal.pone.0054649.g002
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However, there were no significant differences between non-
transfected and transient human CLMP (wild-type or mutant
(V124D)) transfected CHO cells after 24 hours or 48 hours of
incubation (see Figure 3). We concluded that CLMP does not act
like CDH1 as a strong cell-cell adhesion molecule.
Discussion
Loss-of function mutations in CLMP were found in CSBS
patients [4]. These patients have a congenital short small intestine
with a mean length of 50 cm compared to a normal length of
250 cm at birth. CLMP is a trans-membrane protein and co-
localizes with the tight junction proteins ZO-1 [1,4,5] and
occluding [1]. Immunostaining on human embryos showed that
CLMP was expressed in many tissues including the gut. Knock
down experiments of the orthologue in zebrafish resulted in
general developmental defects including an affected intestine.
Goblet cells are normally present in the mid intestine in zebrafish
(which resembles the small intestine in humans), and can therefore
be used as a marker for this epithelial tissue. Since the goblet cells
were absent in the morphant zebrafish, knock down of the
orthologue of CLMP in zebrafish would probably result in the
absence of the small intestine. All these findings suggest that
CLMP has an important role in intestinal development, although
its function is still largely unclear [4]. However, it is known that
transient transfection of human CLMP into human intestinal
epithelial T84 cells showed CLMP localization at the cell-cell
membrane contacts [4]. It is also known that CLMP co-localizes
with tight junction proteins, and is therefore claimed as a tight
junction-associated protein. Because tight junction proteins play
an important role in proliferation [7,8], we have suggested that
loss-of-function of CLMP might affect proliferation [4]. Moreover,
it was shown that transfection of human CLMP into MDCK cells
increases transepithelial resistance [1]. Whether it is proliferation,
or transepithelial resistance, or indeed another process in which
CLMP plays a crucial role and that has impact on the
pathophysiology of CSBS, is still unknown.
To elucidate the function of CLMP we performed several
functional assays using T84 cells as a model. As previously
reported, transient transfection of human CLMP into T84 cells
showed localization of WT-CLMP at the cell membrane and
mislocalization of mutant-CLMP (V124D) in the cytoplasm [4].
Although others have shown that transfection of human CLMP
into MDCK cells increases transepithelial electrical resistance [1],
we did not observe any differences in the transepithelial electrical
resistance in T84 cells. We cannot say whether this discrepancy is
due to the use of distinct cell types (MDCK versus T84) or to the
fact that CLMP is simply not involved in this process. MDCK cells
are kidney cells derived from a seemingly normal adult female
cocker spaniel. Many different strains of the MDCK cell line are
available and the transepithelial resistance in these different strains
differs depending on the tight junction proteins that are expressed
[12]. This illustrates that even in the same cell line, different results
can be obtained. Unfortunately, Raschperger et al did not mention
which strain of the MDCK cell line they used [1]. T84 cells are
human colon carcinoma cells that have been widely used to study
intestinal epithelial function [9–11]. We would therefore like to
argue that T84 cells form a more representative model for
studying the function of CLMP than MDCK cells.
We reported earlier that the missense mutation in CLMP, which
was identified in one of the CSBS patients, leads to CLMP
cytoplasmatic mislocalization [4]. To study whether this missense
mutation would also affect the adhesion properties of CLMP, we
performed a cell aggregation assay using a widely accepted
protocol implemented by Boterberg et al (Metastasis Research
Protocols) [13]. As a positive control we transfected CHO cells
with cadherin 1, also called epithelial or E-cadherin, a cell-cell
Figure 3. No significant difference was observed in cell aggregation between CHO cells transfected with and without CLMP (wild-
type and mutant (V124D)). A. Mock, CHO cells that were not transfected. B. CHO cells transfected with CDH1. C. CHO cells transfected with wild-
type-CLMP. D. CHO cells transfected with mutant-CLMP (V124D).
doi:10.1371/journal.pone.0054649.g003
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adhesion protein that is an important component of the adherens
junction [14,15]. In our assay, transfection of CDH1 resulted in
large aggregates, but we did not observe wild-type CLMP acting as
a strong cell-cell adhesion protein. In the previous reports that
claim that CLMP acts as an adhesion protein, the assays were
performed differently. Raschperger et al used CAR as a positive
control [1]. Eguchi et al used low- and high-CLMP expressing
stably transfected cell lines and observed a significant difference in
the size of the aggregates [6]. The incubation time that
Raschperger et al and Eguchi et al used in the aggregation assays
was shorter, 60 minutes and 90 minutes compared to the
incubation time of 24 hours and 48 hours we used in our
experiments. Differences in the formation of aggregations might
be found in a shorter time frame, while they probably become
equal after a longer incubation time. This might well explain why
we were not able to confirm the previous findings. However, when
we compare our figures with those of both Raschperger et al and
Eguchi et al, we notice that the size of the aggregates we observed
in CHO cells transfected with CDH1 was far bigger. In addition,
the figures in the previous reports are much closer to our figures
for the CLMP-transfected CHO cells than to our positive control,
CHO cells transfected with CDH1. CLMP might have some
adhesion capacity comparable with CAR, but based on our assays
we have to conclude that CLMP is not a strong adhesion molecule
like CDH1.
Because CLMP co-localizes with tight junction proteins and
tight junction proteins play an important role in proliferation
[7,8], we thought that loss-of-function of CLMP might affect
proliferation [4]. However, in our proliferation assay in T84 cells,
we could not elucidate a role for CLMP in proliferation and based
on our assays in T84 cells, CLMP also does not play a role in
migration and cell viability.
From our results we have to conclude that CLMP does not play
a major role in cell-cell adhesion, nor does it affect migration,
proliferation, cell viability and transepithelial electrical resistance
in T84 cells. The fact that T84 cells do not express CLMP, but do
form proper tight junctions, points to the conclusion that CLMP
cannot be essential for tight junction formation. Thus, although
CLMP co-localizes with tight junction proteins, its function is
probably not directly related to the tight junction. More research is
needed to better understand the function of CLMP and why loss-
of-function mutations in CLMP cause Congenital Short Bowel
Syndrome.
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